Home › Products › Others › Azitrix 10mcg Transdermal Patch
Azitrix 10mcg Transdermal Patch
Salt Composition: BUPRENORPHINE TRANSDERMAL PATCH
- Manufacturer: ERIS LIFESCIENCES LIMITED
- Pack Size: 1 PATCH(s)
- Dosage Form: PATCH
- Strength: 10MCG
- Prescription Required
- Storage: Store Azitrix 10mcg Transdermal Patch in a cool, dry place, away from direct sunlight. Keep the patches sealed in their original packaging until use to avoid moisture exposure. Do not store in the refrigerator or freezer. Keep out of reach of children and pets, as accidental exposure could be harmful.
₹1097.00₹1290.00
Inclusive of all taxes
Product Introduction
Azitrix 10mcg Transdermal Patch contains Buprenorphine, a potent opioid analgesic indicated in the management of moderate to severe pain. It belongs to the opioid class of medications and functions by binding to opioid receptors in the brain and spinal cord, thereby altering pain perception. The transdermal patch formulation delivers continuous, long-acting relief, making it appropriate for chronic pain management in patients requiring around-the-clock pain control. This medication is often prescribed for patients who have not responded adequately to other pain management options and may be used as part of a comprehensive treatment plan for pain management. The patch provides consistent drug delivery through the skin over an extended period, typically 7 days. Important considerations include a history of drug addiction, respiratory conditions, or liver or kidney problems. The patch is contraindicated in patients with known hypersensitivity to Buprenorphine or other opioid medications.
Uses
Pain Management: Azitrix 10mcg Transdermal Patch is primarily used for the management of chronic moderate to severe pain in patients who require continuous opioid analgesia.
How it works
Buprenorphine, the active ingredient in Azitrix 10mcg Transdermal Patch, works by binding to opioid receptors in the brain and spinal cord. This action modifies the body's pain signals and provides long-term analgesia. The transdermal patch delivers Buprenorphine through the skin, allowing for steady medication release and pain relief over a period of several days, making it ideal for managing chronic pain.
Side Effects
While Azitrix 10mcg Transdermal Patch is generally safe when used as prescribed, some individuals may experience side effects. Common side effects include: Serious Side Effects: Respiratory depression Severe allergic reactions (rash, itching, swelling) Hypotension (low blood pressure) Severe dizziness or fainting Common Side Effects: Drowsiness or fatigue Headache Nausea or vomiting Constipation Skin irritation at the patch site If you experience any of these side effects or unusual symptoms, contact your healthcare provider immediately.
References
- Babalonis, S. et al. (2017). Buprenorphine and its role in chronic pain management. Journal of Pain Research. [Accessed 14th July 2023] https://pubmed.ncbi.nlm.nih.gov/37897592/
- National Institute on Drug Abuse (NIDA), Buprenorphine for Opioid Addiction. [Accessed 14th July 2023] https://nida.nih.gov/research-topics/treatment
Safety Advice
Pregnancy: Consult Your Doctor The safety of Buprenorphine during pregnancy has not been fully established. Buprenorphine is classified as a Category C drug, meaning the risks and benefits should be carefully considered before use. Discuss potential risks with your physician if you are pregnant or planning to become pregnant.
Lungs: Consult Your Doctor It can cause some side effects. Please consult a physician before taking.
Breastfeeding: Consult Your Doctor Buprenorphine passes into breast milk and may harm the infant. Breastfeeding while using Azitrix 10mcg Transdermal Patch is not recommended without medical advice.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.